Cargando…
Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement
Antithrombotic therapy for stroke prevention in patients with atrial fibrillation (AF) has dramatically shifted from warfarin, a vitamin K antagonist, to the direct oral anticoagulants (DOACs) such as dabigatran, apixaban, and rivaroxaban. In patients with contraindications to oral anticoagulation,...
Autores principales: | Ahuja, Tania, Murphy, Scarlett, Sartori, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512040/ https://www.ncbi.nlm.nih.gov/pubmed/31183220 http://dx.doi.org/10.1155/2019/5247105 |
Ejemplares similares
-
Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients
por: Zhai, Zhengqin, et al.
Publicado: (2019) -
Left Atrial Appendage Closure – The WATCHMAN Device
por: Akinapelli, Abhilash, et al.
Publicado: (2015) -
Successful WATCHMAN Device Placement Despite Left Atrial Appendage Perforation in Two Cases
por: Prabhakar Bhat, Sangeeta, et al.
Publicado: (2021) -
Therapeutic Dilemma of Natural Watchman: Congenital Absence of the Left Atrial Appendage
por: Nandar, Phoo Pwint, et al.
Publicado: (2018) -
Left atrial thrombus after placement of watchman device
por: Isang, Emmanuel, et al.
Publicado: (2022)